BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14701864)

  • 1. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.
    Gao G; Plaas A; Thompson VP; Jin S; Zuo F; Sandy JD
    J Biol Chem; 2004 Mar; 279(11):10042-51. PubMed ID: 14701864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
    Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
    Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
    Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
    J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
    Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H
    J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.
    Westling J; Fosang AJ; Last K; Thompson VP; Tomkinson KN; Hebert T; McDonagh T; Collins-Racie LA; LaVallie ER; Morris EA; Sandy JD
    J Biol Chem; 2002 May; 277(18):16059-66. PubMed ID: 11854269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of covalently attached chondroitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13.
    Miwa HE; Gerken TA; Hering TM
    Matrix Biol; 2006 Oct; 25(8):534-45. PubMed ID: 16945513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of the amino-terminus of the recombinant aggrecan rAgg1mut leads to reduced cleavage at the aggrecanase site. Efficient aggrecanase catabolism may depend on multiple substrate interactions.
    Hörber C; Büttner FH; Kern C; Schmiedeknecht G; Bartnik E
    Matrix Biol; 2000 Nov; 19(6):533-43. PubMed ID: 11068207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).
    Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E
    J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix.
    Kokenyesi R
    J Cell Biochem; 2001 Aug 1-9; 83(2):259-70. PubMed ID: 11573243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1.
    Kokenyesi R; Bernfield M
    J Biol Chem; 1994 Apr; 269(16):12304-9. PubMed ID: 8163535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.
    Nakamura H; Fujii Y; Inoki I; Sugimoto K; Tanzawa K; Matsuki H; Miura R; Yamaguchi Y; Okada Y
    J Biol Chem; 2000 Dec; 275(49):38885-90. PubMed ID: 10986281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.
    Itoh Y; Kajita M; Kinoh H; Mori H; Okada A; Seiki M
    J Biol Chem; 1999 Nov; 274(48):34260-6. PubMed ID: 10567400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells.
    Salmivirta M; Mali M; Heino J; Hermonen J; Jalkanen M
    Exp Cell Res; 1994 Nov; 215(1):180-8. PubMed ID: 7957667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase.
    Fitzgerald ML; Wang Z; Park PW; Murphy G; Bernfield M
    J Cell Biol; 2000 Feb; 148(4):811-24. PubMed ID: 10684261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia.
    Rapraeger A
    J Cell Biol; 1989 Nov; 109(5):2509-18. PubMed ID: 2509487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal human keratinocytes bind to the alpha3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1.
    Okamoto O; Bachy S; Odenthal U; Bernaud J; Rigal D; Lortat-Jacob H; Smyth N; Rousselle P
    J Biol Chem; 2003 Nov; 278(45):44168-77. PubMed ID: 12947106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
    Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
    J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.
    Westling J; Gottschall PE; Thompson VP; Cockburn A; Perides G; Zimmermann DR; Sandy JD
    Biochem J; 2004 Feb; 377(Pt 3):787-95. PubMed ID: 14561220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.